Header graphic for print
Socially Aware Blog The Law and Business of Social Media

Category Archives: FDA Regulations

Subscribe to FDA Regulations RSS Feed

Influencer Marketing: Tips for a Successful (and Legal) Advertising Campaign

Posted in Compliance, Endorsement Guides, FDA Regulations, FTC, IP, Marketing, Online Endorsements

In an age of explosive growth for social media and declining TV viewership numbers, companies are partnering with so-called “influencers” to help the companies grow their brands. Popular users of Instagram, Vine, YouTube and other social media sites have gained celebrity status, generating millions of views, impressions and “likes” with every upload. Capitalizing on the… Continue Reading

Post Wisely

Posted in FDA Regulations

From our sister blog, MoFo Tech: Two FDA Guidelines Help Life Sciences Companies Solve Social Media Conundrums Social media presents new challenges for life sciences companies. Companies that post about their products on space-constrained social media platforms such as Twitter or Facebook don’t have the luxury of a full page or a long voiceover listing risks… Continue Reading

Hot Off the Press: The August Issue of Our Socially Aware Newsletter Is Now Available

Posted in DMCA, FDA Regulations, Litigation, Privacy, Statistics, Supreme Court, Wearable Computers

The latest issue of our Socially Aware newsletter is now available here. In this issue of Socially Aware, our Burton Award-winning guide to the law and business of social media, we examine the use of the Computer Fraud and Abuse Act to combat web scraping; we explore the launch of Google Glass in the UK… Continue Reading

Drugs and the Internet: FDA Distributes New Draft Guidance Regarding Social Media Platforms and Prescription Drugs

Posted in FDA Regulations

Last week the Food and Drug Administration (FDA) promulgated two much-anticipated draft guidance documents on using social media to present information about prescription drugs and medical devices. The draft guidance documents, which were originally promised by the FDA in 2010, represent the FDA’s latest attempt to provide direction for drug and device manufacturers concerning how… Continue Reading

FDA Letter to Mobile App Developer Signals Regulatory Scheme

Posted in FDA Regulations

In late May 2013, the U.S. Food and Drug Administration (FDA) sent an enforcement letter to a mobile medical app developer for failing to obtain a 510(k) clearance before marketing the app, which the FDA said appears to be a “device” under section 201(h) of the Federal Food, Drug, and Cosmetic Act (FDCA). The mobile… Continue Reading